Citizens Business Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,500	Closed	-$510K	–	123
2022 Q2	$510K	Hold	3,500	–	–	0.07%	191
2022 Q1	$572K	Hold	3,500	–	–	0.07%	190
2021 Q4	$594K	Hold	3,500	–	–	0.07%	195
2021 Q3	$661K	Hold	3,500	–	–	0.09%	183
2021 Q2	$593K	Hold	3,500	–	–	0.08%	193
2021 Q1	$494K	Hold	3,500	–	–	0.07%	191
2020 Q4	$455K	Hold	3,500	–	–	0.07%	195
2020 Q3	$510K	Hold	3,500	–	–	0.09%	172
2020 Q2	$518K	Hold	3,500	–	–	0.09%	176
2020 Q1	$381K	Hold	3,500	–	–	0.08%	187
2019 Q4	$403K	Hold	3,500	–	–	0.07%	200
2019 Q3	$281K	Hold	3,500	–	–	0.05%	222
2019 Q2	$254K	Hold	3,500	–	–	0.04%	231
2019 Q1	$327K	Hold	3,500	–	–	0.06%	219
2018 Q4	$255K	Hold	3,500	–	–	0.05%	239
2018 Q3	$306K	Hold	3,500	–	–	0.05%	241
2018 Q2	$345K	Hold	3,500	–	–	0.06%	230
2018 Q1	$417K	Hold	3,500	–	–	0.07%	217
2017 Q4	$445K	Hold	3,500	–	–	0.07%	222
2017 Q3	$411K	Hold	3,500	–	–	0.07%	224
2017 Q2	$279K	Buy	+3,500	New	+$224K	0.05%	250